Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
959.4 INR | -0.03% | +1.55% | +39.21% |
11:12am | Zydus Lifesciences' Desidustat Tablets Get Nod from China Regulator | MT |
Apr. 22 | Zydus Arm Get UK Drug Regulator's Marketing Approval for Nulibry as MoCD Type A Treatment | MT |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited